Ps. Subramaniam et al., TYPE-I INTERFERON INDUCTION OF THE CDK-INHIBITOR P21(WAF1) IS ACCOMPANIED BY ORDERED G1 ARREST, DIFFERENTIATION AND APOPTOSIS OF THE DAUDI B-CELL LINE, Oncogene, 16(14), 1998, pp. 1885-1890
We show, in this study, that type I IFN induction of the cyclin-depend
ent kinase (cdk) inhibitor p21(WAF1) in the human Burkitt lymphoma B c
ell-line Daudi and ensuing cell cycle arrest correlate with the termin
al differentiation of these cells, and is ultimately followed by apopt
osis and cell death. The expression of p21(WAF1) paralleled the onset
of G1 arrest and the reduction of surface IgM expression which was use
d as a marker of the differentiation response, and the IFN treated cel
ls acquired a typical plasma cell-like morphology. The type II IFN IFN
gamma, which does not inhibit the growth of Daudi cells, did not indu
ce the expression of p21(WAF1), nor affect the expression of surface I
gM. The induction of p21(WAF1) which paralleled the inhibition of the
phosphorylation of the retinoblastoma protein, pRB, was preceded by th
e strong reduction in c-myc levels, We propose that the coupled down-r
egulation of c-myc and induction of p21(WAF1) may be crucial to the in
duction of differentiation and G1 arrest in Daudi cells by type I IFN.
Growth arrest and differentiation was followed by apoptosis and cell
death, and was accompanied by the induction of the activity of the apo
ptotic ICE-family protease CPP32. G1 arrest and differentiation follow
ed by apoptotic cell death are characteristics of terminal differentia
tion. Thus, our data suggest that the induction of p21(WAF1) and G1 ar
rest mediated by type I IFN in Daudi cells is part of terminal differe
ntiation response in these cells, highlighting a role for type I IFN a
s B cell terminal differentiation factors.